HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brent Appelman Selected Research

COVID-19

1/2022A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern.
12/2021Inflammatory biomarkers at hospital discharge are associated with readmission and death in patients hospitalized for COVID-19.
11/2021Cross-reactive antibodies after SARS-CoV-2 infection and vaccination.
10/2021Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination.
9/2021Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination.
6/2021Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brent Appelman Research Topics

Disease

6COVID-19
01/2022 - 06/2021
1Infections
01/2022

Drug/Important Bio-Agent (IBA)

4VaccinesIBA
01/2022 - 06/2021
2BNT162 VaccineIBA
01/2022 - 10/2021
1Neutralizing AntibodiesIBA
01/2022
1mRNA VaccinesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
12/2021
1Proteins (Proteins, Gene)FDA Link
11/2021
1AntibodiesIBA
11/2021
1altersolanol AIBA
11/2021
1Messenger RNA (mRNA)IBA
10/2021